Experience in preparing obese patients for infertility treatment

1. Correa A., Marcinkevage J. Prepregnancy obesity and the risk of birth defects: an update. Nutr Rev. 2013; 71(Suppl. 1): 68–77. doi: 10.1111/nure.12058.
2. Dolin C.D., Kominiarek M.A. Pregnancy in women with obesity. Obstet Gynecol Clin North Am. 2018; 45: 217–32. http://dx.doi.org/10.1016/j.ogc.2018.01.005
3. Sneed M.L., Uhler M.L., Grotjan H.E., et al. Body mass index: impact on IVF success appears age-related. Hum Reprod. 2008; 23(8): 1835–9. https://doi.org/10.1093/humrep/den188
4. Poston L., Caleyachetty R., Cnattingius S., Corvalan C., Uauy R., Herring S., et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol.2016; 4(12): 1025–1036.doi: 10.1016/S2213-8587(16)30217-0.
5. Rasmussen S.A., Chu S.Y., Kim S.Y., Schmid C.H., Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am. J. Obstet. Gynecol. 2008; 198(6): 611–9. doi: 10.1016/j.ajog.2008.04.021.
6. Poston L., Caleyachetty R., Cnattingius S., Corvalan C., Uauy R., Herring S., et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2018; 4: 1025–36. doi: 10.1016/S2213-8587(16)30217-0.
7. Most J., Marlatt K. L., Altazan A. D., Redman L. M. Advances in assessing body composition during pregnancy. Eur J Clin Nutr. 2018; 72: 645–56.doi: 10.1038/s41430-018-0152-8.
8. Bozkurt L., Gobl C. S., Hormayer A.T., Luger A., Pacini G., Kautzky-Willer A. The impact of preconceptional obesity on trajectories of maternal lipids during gestation. Sci. Rep.2016; 6: 29971. doi: 10.1038/srep29971.
9. Burton G.J., Jauniaux E. Oxidative stress. Best Practice & Research Clinical Obstetrics & Gynaecology. 2011; 25(3): 287–99. doi: 10.1016/j.bpobgyn.2010.10.016
10. Alcala M., Sanchez-Vera I., Sevillano J., Herrero L., Serra D., Ramos M.P., et al. Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity. 2015; 23(8): 1598–1606.doi: 10.1002/oby.21135
11. Agarwal A., Aziz N., Rizk B. Studies on Women’s Health. HumanaPress, NewYork; 2013; 33–60. doi:https://doi.org/10.1007/978-1-62703-041-0.
12. Matsuda M., Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes. Res. Clin. Pract. 2013; 7: 330–341. doi: 10.1016/j.orcp.2013.05.004
13. Agarwal A., Aponte-Mellado A., Premkumar B.J., et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012; 10(1): 49. doi: 10.1186/1477-7827-10-49.
14. Savini I., Catani M.V., Evangelista D., Gasperi V., Avigliano L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int. J. Mol. Sci. 2013; 14: 10497–538. doi: 10.3390/ijms140510497.
15. Alcala M., Calderon-Dominguez M., Serra D., Herrero L., Ramos M.P., Viana M. Short-term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice. PLoS One 2017; 23–56. https://doi.org/10.1371/journal.pone.0186579
16. Wu F., Tian F.J., Lin Y. Oxidative stress in placenta: health and diseases. Biomed. Res. Int. 2015; 293271. https://doi.org/10.1155/2015/293271
17. Malti N., Merzouk H., Merzouk S.A., Loukidi B., Karaouzene N., Malti A., et al. Oxidative stress and maternal obesity: feto-placental unit interaction. Placenta 2014; 35: 411–6. doi: 10.1016/j.placenta.2014.03.010.
18. Ock C.Y., Kim E.H., Choi D.J., Lee H.J., Hahm K.B., Chung M.H. 8-Hydroxydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicatedgastrointestinal diseases. World J Gastroenterol. 2012; 18(4): 302–8. doi: 10.3748/wjg.v18.i4.302.
19. Nguyen D.M., El-Serag H.B. The epidemiology of obesity. Gastroenterol Clin North Am. 2010; 39(1):1–7. https://doi.org/10.1016/j.gtc.2009.12.014
20. Дедов И.И., Романцова Т.И., Шестакова М.В. Рациональный подход к терапии пациентов с СД2 и ожирением: итоги всероссийской наблюдательной программы «АВРОРА» Ожирение и метаболизм. 2018; 15(4): 48–58. [Dedov I.I., Romantsova T.I., Shestakova M.V. Rational approach to the treatment of patients with diabetes and obesity: the results of the all-Russian observational program “AURORA” Obesity and metabolism. 2018; 15 (4): 48–58. (in Russian)]
21. Востриков В.В., Маркова Е.А., Кузнецова Т.А., Елизарьев А.Ю. Этиология и патогенез синдрома гиперстимуляции яичников. Современные аспекты диагностики, лечения и профилактики. Барнаул: Алтайский медицинский университет, 2016. 60 с. [Vostrikov V.V., Markova E.A., Kuznetsova T.A., Elizaryev A. Y. Barnaul: Altai medical University, 2016. 60 p. (in Russian)].
22. Иванова А.Р. Медико-психологические особенности женщин во время лечения бесплодия: автореф. дис. … канд. мед. наук. М., 2010. [Ivanova A.R.Medical and psychological characteristics of women during the treatment of infertility: author. Dis…. Cand. M., 2010. (in Russian)].
23. Жук Т.В., Яворская С.Д., Востриков В.В., Немцева Г.В. Прогноз эффективности экстракорпорального оплодотворения у пациенток с трубно-перитонеальным бесплодием и ожирением. Российский вестник акушера-гинеколога. 2019; 19(1): 66–9. [Zhuk T.V., Yavorskaya S.D.,Vostrikov V.V., Nemtseva G.V. Prognosis of in vitro fertilization effectiveness in patients with tuboperitoneal infertility and obesity. Russian bulletin of obstetrician-ginaecologist. 2019; 2019; 19(1): 66–9 (in Russian)].doi: 10.17116/rosakush20191901166

Received 05.02.2020

Accepted 07.02.2020